Phenotypic variability associated with 14 splice-site mutations in the NF2 gene
- PMID: 9605590
Phenotypic variability associated with 14 splice-site mutations in the NF2 gene
Abstract
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder caused by mutations in the NF2 gene. Patients carrying NF2 mutations are predisposed to cerebral and spinal tumors with bilateral vestibular schwannomas as the hallmark. Using single strand conformation polymorphism and temperature gradient gel electrophoresis analysis, we have screened 87 unrelated NF2 patients for mutations in the NF2 gene. In this study, we report phenotypes associated with 14 splice-site mutations carried by 14 propositi and 11 relatives. The mutations were distributed in exons 2, 3, 5, 7, 8, 14, and 15. These splice-site mutations were associated with various phenotypes, from severe to asymptomatic. Phenotypic variation was also observed within families. Mutations downstream from exon 8 resulted more often in mild phenotypes. No meningiomas were found in any of 13 affected or mutation bearing individuals from three families with splice-site mutations of exons 14 and 15. These data suggest that splice-site alteration is a relatively common cause of NF2, and that unlike other mutations the clinical outcomes of splice-site mutations in the NF2 gene are variable. These results add to the growing body of information on genotype-phenotype correlation in NF2.
Similar articles
-
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.J Med Genet. 2005 Jul;42(7):540-6. doi: 10.1136/jmg.2004.029504. J Med Genet. 2005. PMID: 15994874 Free PMC article. Review.
-
Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).Genet Epidemiol. 2002 Oct;23(3):245-59. doi: 10.1002/gepi.10181. Genet Epidemiol. 2002. PMID: 12384977
-
Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.Am J Otol. 1997 Nov;18(6):754-60. Am J Otol. 1997. PMID: 9391673
-
A point mutation associated with a severe phenotype of neurofibromatosis 2.Ann Neurol. 1996 Sep;40(3):440-5. doi: 10.1002/ana.410400313. Ann Neurol. 1996. PMID: 8797533 Review.
-
Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?Genes Chromosomes Cancer. 1999 Jun;25(2):184-90. Genes Chromosomes Cancer. 1999. PMID: 10338003
Cited by
-
In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2.Eur J Hum Genet. 2013 Jul;21(7):769-73. doi: 10.1038/ejhg.2012.261. Epub 2012 Nov 28. Eur J Hum Genet. 2013. PMID: 23188051 Free PMC article.
-
A targeted deleterious allele of the splicing factor SCNM1 in the mouse.Genetics. 2008 Nov;180(3):1419-27. doi: 10.1534/genetics.108.094227. Epub 2008 Sep 14. Genetics. 2008. PMID: 18791226 Free PMC article.
-
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.Am J Hum Genet. 2004 Aug;75(2):231-9. doi: 10.1086/422700. Epub 2004 Jun 9. Am J Hum Genet. 2004. PMID: 15190457 Free PMC article.
-
Genetic Alterations in Patients with NF2-Related Schwannomatosis and Sporadic Vestibular Schwannomas.Cancers (Basel). 2025 Jan 24;17(3):393. doi: 10.3390/cancers17030393. Cancers (Basel). 2025. PMID: 39941762 Free PMC article.
-
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.J Med Genet. 2005 Jul;42(7):540-6. doi: 10.1136/jmg.2004.029504. J Med Genet. 2005. PMID: 15994874 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous